Get the Stockscreener App
0.687
17.72%
-0.148
After Hours:
.70
0.013
+1.89%
Eterna Therapeutics Inc Stock (ERNA) Forecast
The Eterna Therapeutics Inc (ERNA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.8696, representing a +26.59% increase from the current price of $0.687. The highest analyst price target is $1.0796, and the lowest is $0.6596.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ERNA Price Target
Average 0.7949
(+15.71% Upside)
Is Eterna Therapeutics Inc (ERNA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 26.21 | Buy |
| STOCH(9,6) | 20.13 | Neutral |
| STOCHRSI(14) | 6.1712 | Buy |
| MACD(12,26) | -0.068 | Sell |
| ADX(14) | 18.39 | Neutral |
| William %R | -93.83 | Buy |
| CCI(14) | -261.22 | Sell |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.004
Sell
|
0.945
Sell
|
| MA20 |
1.0117
Sell
|
1.0027
Sell
|
| MA50 |
1.1109
Sell
|
1.1517
Sell
|
| MA100 |
1.468
Sell
|
1.3649
Sell
|
| MA200 |
1.7191
Sell
|
1.5802
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ERNA could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on ERNA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 26.21 indicates that ERNA is oversold. This indicates that ERNA price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 20.13 indicates that ERNA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 6.1712 indicates that ERNA is oversold. This suggests that ERNA price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.39 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -261.22 indicates that ERNA is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term ERNA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Eterna Therapeutics Inc financial reports and earnings history, Eterna Therapeutics Inc (ERNA) stock could reach $4.4735 by 2030, $18.45 by 2040 and $20.62 by 2050. See the projected annual prices until 2050 of the Eterna Therapeutics Inc stock below:
- Eterna Therapeutics Inc (ERNA) is expected to reach an average price of $11.36 in 2035, with a high prediction of $11.80 and a low estimate of $11.49. This indicates an $1,553% rise from the last recorded price of $0.687.
- Eterna Therapeutics Inc (ERNA) stock is projected to chart a bullish course in 2040, with an average price target of $18.20, representing an $2,549% surge from its current level. The forecast ranges from a conservative $18.42 to a sky-high $18.45.
- Our analysts predict Eterna Therapeutics Inc (ERNA) to jump 1,783% by 2045, soaring from $13.13 to an average price of $12.93, potentially reaching $13.67. While $13.13 is the low estimate, the potential upside is significant.
- Eterna Therapeutics Inc (ERNA) stock is expected to climb by 2050, reaching an average of $20.21, a $2,842% jump from its current level. However, a wide range of estimates exists, with high and low targets of $20.62 and $20.52, respectively, highlighting the market's uncertainty.
Eterna Therapeutics Inc Stock (ERNA) Year by Year Forecast
Eterna Therapeutics Inc Stock (ERNA) Price Forecast for 2024
Our forecast for ERNA stock price in 2024 now indicates an average price target of $1.4416 with a high forecast of $2.57 and a low forecast of $0.3132. The average prediction reflects an increase of +109.84% from the last recorded price of $0.687.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $0.8486 | $0.6596 | $1.0796 | +23.52% |
Eterna Therapeutics Inc Stock (ERNA) Price Forecast for 2025
Eterna Therapeutics Inc Stock (ERNA) is expected to reach an average price of $0.7949 in 2025, with a high prediction of $1.587 and a low estimate of $0.00286. This indicates an +15.71% rise from the last recorded price of $0.687.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.0618 | $0.0364 | $0.8289 | -91.01% |
| February, 2025 | $0.0295 | $0.1795 | $0.2575 | -95.71% |
| March, 2025 | $0.6518 | $0.00286 | $0.9182 | -5.13% |
| April, 2025 | $0.5884 | $0.2215 | $0.8678 | -14.35% |
| May, 2025 | $0.5277 | $0.3907 | $0.7981 | -23.19% |
| June, 2025 | $1.197 | $0.41 | $1.587 | +74.23% |
| July, 2025 | $1.2286 | $1.1286 | $1.5539 | +78.83% |
| August, 2025 | $0.07 | $0.3212 | $1.327 | -89.81% |
| September, 2025 | $0.0686 | $0.126 | $0.4286 | -90.02% |
| October, 2025 | $0.6482 | $0.2468 | $0.2182 | -5.65% |
| November, 2025 | $0.9896 | $1.0689 | $0.9096 | +44.05% |
| December, 2025 | $0.1664 | $0.7511 | $0.6057 | -75.77% |
Eterna Therapeutics Inc Stock (ERNA) Price Forecast for 2026
The predicted value for Eterna Therapeutics Inc (ERNA) in 2026 is set at an average of $0.768. Estimates vary from a peak of $1.535 to a trough of $0.00106, indicating an +11.79% surge from the present price of $0.687.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.00566 | $0.1979 | $0.042 | -99.18% |
| February, 2026 | $0.3393 | $0.3032 | $0.2676 | -50.61% |
| March, 2026 | $0.6307 | $0.4746 | $0.2607 | -8.19% |
| April, 2026 | $1.1875 | $0.5713 | $0.7175 | +72.85% |
| May, 2026 | $1.3289 | $1.3029 | $1.2439 | +93.44% |
| June, 2026 | $0.8049 | $1.2804 | $1.3397 | +17.16% |
| July, 2026 | $0.6272 | $0.4318 | $0.3857 | -8.71% |
| August, 2026 | $0.5036 | $0.4932 | $0.6025 | -26.70% |
| September, 2026 | $0.1554 | $0.3629 | $0.37 | -77.38% |
| October, 2026 | $0.4832 | $0.0639 | $0.6039 | -29.66% |
| November, 2026 | $0.0283 | $0.2071 | $0.6078 | -95.88% |
| December, 2026 | $1.6561 | $0.00106 | $1.535 | +141.06% |
Eterna Therapeutics Inc Stock (ERNA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Eterna Therapeutics Inc (ERNA) is $2.0536, with a high forecast of $2.5445 and a low forecast of $1.5627. This indicates an +198.92% increase from the last price of $0.687.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.0282 | $1.799 | $1.5572 | +195.23% |
| February, 2027 | $2.44 | $1.9584 | $1.8404 | +255.16% |
| March, 2027 | $2.3355 | $2.3355 | $2.4595 | +239.96% |
| April, 2027 | $1.6477 | $2.1177 | $2.1186 | +139.84% |
| May, 2027 | $1.5998 | $1.6368 | $1.4933 | +132.87% |
| June, 2027 | $2.065 | $1.852 | $1.6696 | +200.58% |
| July, 2027 | $1.7177 | $1.8871 | $1.7041 | +150.02% |
| August, 2027 | $2.3894 | $1.9002 | $2.2535 | +247.80% |
| September, 2027 | $2.7145 | $2.6023 | $2.5445 | +295.12% |
| October, 2027 | $1.5966 | $2.1574 | $2.1275 | +132.40% |
| November, 2027 | $1.9189 | $1.5627 | $1.7088 | +179.31% |
| December, 2027 | $1.4639 | $1.5748 | $1.4548 | +113.09% |
Eterna Therapeutics Inc Stock (ERNA) Price Forecast for 2028
In 2028, Eterna Therapeutics Inc (ERNA) is projected to reach an average price of $2.3238, with a high projection of $4.0093 and a low estimate of $0.6382. This indicates an +238.25% rise from the last price of $0.687.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.7719 | $1.2161 | $1.39 | +12.36% |
| February, 2028 | $0.6382 | $0.6382 | $0.4422 | -7.10% |
| March, 2028 | $0.7658 | $0.6713 | $0.8604 | +11.47% |
| April, 2028 | $3.3119 | $3.472 | $3.245 | +382.09% |
| May, 2028 | $3.6757 | $3.4729 | $3.2857 | +435.04% |
| June, 2028 | $4.2486 | $3.9464 | $3.9886 | +518.42% |
| July, 2028 | $3.7914 | $3.8607 | $4.0093 | +451.88% |
| August, 2028 | $3.035 | $3.136 | $3.5621 | +341.78% |
| September, 2028 | $3.2629 | $3.0757 | $3.0716 | +374.94% |
| October, 2028 | $2.9907 | $3.2293 | $2.9893 | +335.33% |
| November, 2028 | $3.4093 | $3.2028 | $3.0443 | +396.26% |
| December, 2028 | $3.7872 | $3.745 | $3.5672 | +451.26% |
Eterna Therapeutics Inc Stock (ERNA) Price Forecast for 2029
The 2029 price forecast for Eterna Therapeutics Inc Stock (ERNA) is $3.5717 on average, with a high prediction of $5.5591 and a low estimate of $1.5843. This represents an +419.90% increase from the previous price of $0.687.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.1652 | $3.6407 | $3.7493 | +360.73% |
| February, 2029 | $2.6041 | $2.6936 | $2.7214 | +279.05% |
| March, 2029 | $2.6564 | $2.6564 | $2.815 | +286.67% |
| April, 2029 | $2.5693 | $2.6686 | $2.432 | +273.99% |
| May, 2029 | $1.5029 | $1.7229 | $2.41 | +118.76% |
| June, 2029 | $1.5357 | $1.5843 | $1.3436 | +123.54% |
| July, 2029 | $5.06 | $1.7679 | $4.955 | +636.54% |
| August, 2029 | $4.952 | $5.1336 | $4.8968 | +620.81% |
| September, 2029 | $5.4455 | $5.2059 | $5.0155 | +692.65% |
| October, 2029 | $5.3675 | $5.6775 | $5.5591 | +681.30% |
| November, 2029 | $4.6311 | $5.231 | $5.1443 | +574.10% |
| December, 2029 | $4.3225 | $4.5147 | $4.4195 | +529.18% |
Eterna Therapeutics Inc Stock (ERNA) Price Forecast for 2030
Eterna Therapeutics Inc Stock (ERNA) is expected to reach an average price of $4.5977 in 2030, with a high forecast of $6.665 and a low forecast of $2.5304. This signifies an +569.24% surge from the last price of $0.687.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.6066 | $4.583 | $4.4735 | +570.54% |
| February, 2030 | $4.4602 | $4.5902 | $4.3602 | +549.23% |
| March, 2030 | $5.0238 | $4.507 | $4.5538 | +631.26% |
| April, 2030 | $5.0173 | $5.0973 | $4.9323 | +630.33% |
| May, 2030 | $4.3293 | $4.6743 | $4.9541 | +530.18% |
| June, 2030 | $3.9829 | $3.8245 | $3.7777 | +479.75% |
| July, 2030 | $3.6291 | $3.7381 | $3.9213 | +428.26% |
| August, 2030 | $3.1784 | $3.3859 | $3.4313 | +362.65% |
| September, 2030 | $2.392 | $2.592 | $2.7168 | +248.18% |
| October, 2030 | $2.714 | $2.5304 | $2.654 | +295.04% |
| November, 2030 | $6.7121 | $2.6524 | $6.665 | +877.02% |
| December, 2030 | $6.9364 | $6.7943 | $6.5483 | +909.67% |
3.66%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):